Bryn Mawr Trust CO Charles River Laboratories International, Inc. Transaction History
Bryn Mawr Trust CO
- $5.51 Billion
- Q2 2025
A detailed history of Bryn Mawr Trust CO transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Bryn Mawr Trust CO holds 299 shares of CRL stock, worth $44,473. This represents 0.0% of its overall portfolio holdings.
Number of Shares
299
Previous 197
51.78%
Holding current value
$44,473
Previous $29,000
55.17%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CRL
# of Institutions
610Shares Held
54.5MCall Options Held
722KPut Options Held
847K-
Vanguard Group Inc Valley Forge, PA6.11MShares$908 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$757 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$637 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$356 Million0.07% of portfolio
-
Allspring Global Investments Holdings, LLC2.29MShares$341 Million0.63% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.57B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...